GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>If a company wants to make some sort of a low-priced takeover offer, it would make sense for them to first work the price lower and then make an offer which is well above the current trading point.<

Can you name even one documented case where something like this happened to a biotech company? I emphasize the word documented because you have a tendency to see enemy action in what others regard as routine.